scispace - formally typeset
G

Gail S. Harrison

Researcher at University of Colorado Denver

Publications -  26
Citations -  1484

Gail S. Harrison is an academic researcher from University of Colorado Denver. The author has contributed to research in topics: Silibinin & Transfection. The author has an hindex of 18, co-authored 26 publications receiving 1414 citations. Previous affiliations of Gail S. Harrison include Anschutz Medical Campus & Roosevelt Institute.

Papers
More filters
Journal ArticleDOI

A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients.

TL;DR: It is concluded that 13 g of oral silybin-phytosome daily, in 3 divided doses, appears to be well tolerated in patients with advanced prostate cancer and is the recommended phase II dose.
Journal Article

A DNA cassette containing a trimerized SV40 polyadenylation signal which efficiently blocks spurious plasmid-initiated transcription.

TL;DR: A head-to-tail trimer of the SV40 Bcl I-Bam H1 DNA fragment, specifying polyadenylation of RNA transcripts, was cloned as a cassette flanked by multiple restriction sites to prevent spurious expression of reporter genes resulting from transcriptional initiation in prokaryotic plasmid sequences in transfected mammalian cells.
Journal ArticleDOI

Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages.

TL;DR: It is suggested that silibinin modulates CDKI-CDK-cyclin cascade and activates caspase 3 causing growth inhibition and apoptotic death of human TCC cells, providing a strong rationale for future studies evaluating preventive and/or intervention strategies for silib inin in bladder cancer pre-clinical models.